GammaDelta Therapeutics’ innovative and unique approach to Immunotherapy has the potential to make a significant impact on the treatment of cancer and auto-immune diseases.

Gamma delta T cells are a unique and conserved population of lymphocytes that contribute to many types of immune responses and immunopathologies. The new company is focused on exploiting the unique characteristics of tissue derived gamma delta T cells.

Contact GammaDelta Therapeutics
+44 (0207) 6911122
info@gammadeltatx.com